BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 9068480)

  • 1. Cytoplasmic antineutrophil cytoplasmic antibody-positive vasculitis associated with ulcerative colitis.
    Weir A; Taylor-Robinson SD; Poole S; Pignatelli M; Walters JF; Calam J
    Am J Gastroenterol; 1997 Mar; 92(3):506-8. PubMed ID: 9068480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annular leukocytoclastic vasculitis in a patient with PR3-antineutrophil cytoplasmic antibody-positive ulcerative colitis.
    Gambichler T; Susok L; Abu Rached N; Stücker M; Scheel C
    Eur J Dermatol; 2020 Aug; 30(4):420-421. PubMed ID: 32969801
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes.
    Carlson JA; Chen KR
    Am J Dermatopathol; 2006 Dec; 28(6):486-506. PubMed ID: 17122493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
    Cabral VL; Miszputen SJ; Catapani WR
    Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinuclear antineutrophil cytoplasmic antibody myeloperoxidase-positive vasculitis in association with ulcerative colitis.
    Panani AD; Grigoriadou M; Magira E; Roussos C; Raptis SA
    Clin Rheumatol; 2006 Feb; 25(1):35-7. PubMed ID: 15902516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure?
    Andreani ML; Frascà G; Brusco G; Borgnino L; Biagi F; Gasbarrini G; Corazza GR
    Ann Ital Med Int; 1996; 11(4):254-7. PubMed ID: 9050283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerative colitis associated with leukocytoclastic vasculitis of the skin.
    Tripodi Cutrì F; Salerno R; Lo Schiavo A; Gravina AG; Romano M; Ruocco E
    Dig Liver Dis; 2009 Jul; 41(7):e42-4. PubMed ID: 18799375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antineutrophil cytoplasmic antibodies and nonspecific ulcerative colitis].
    Rojas G; Siegel F; Jorquera J; Ardiles L; Valderrama G; Mezzano S
    Rev Med Chil; 1996 Apr; 124(4):449-55. PubMed ID: 9110485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
    Comfere NI; Macaron NC; Gibson LE
    J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody-associated vasculitis with oculomotor nerve palsy.
    Seishima M; Mizutani Y; Shibuya Y; Arakawa C
    Clin Exp Dermatol; 2009 Mar; 34(2):171-3. PubMed ID: 19187297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to the presence of IgA class antineutrophil cytoplasmic antibodies in ulcerative colitis.
    Esteve M; Mallolas J; Klaassen J; Abad-Lacruz A; Gonzàlez-Huix F; Cabré E; Fernández-Bañares F; Menacho M; Condom E; Martí-Ragué J; Gassull MA
    Am J Gastroenterol; 1998 Apr; 93(4):615-8. PubMed ID: 9580546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis.
    Rovel-Guitera P; Diemert MC; Charuel JL; Laporte JL; Musset L; Chosidow O; Piette JC; Francès C
    Br J Dermatol; 2000 Jul; 143(1):99-103. PubMed ID: 10886142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients.
    Sais G; Vidaller A; Jucglà A; Servitje O; Condom E; Peyri J
    Arch Dermatol; 1998 Mar; 134(3):309-15. PubMed ID: 9521029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature.
    Lombardi G; Annese V; Piepoli A; Bovio P; Latiano A; Napolitano G; Perri F; Conoscitore P; Andriulli A
    Dis Colon Rectum; 2000 Jul; 43(7):999-1007. PubMed ID: 10910250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis.
    Teegen B; Niemann S; Probst C; Schlumberger W; Stöcker W; Komorowski L
    Ann N Y Acad Sci; 2009 Sep; 1173():161-5. PubMed ID: 19758145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe cutaneous vasculitis complicating ulcerative colitis.
    Callen JP
    Arch Dermatol; 1979 Feb; 115(2):226-7. PubMed ID: 426536
    [No Abstract]   [Full Text] [Related]  

  • 18. [An autopsy case of P-ANCA-positive microscopic polyangiitis with multiple cerebral hemorrhagic infarction].
    Sasaki A; Hirato J; Nakazato Y; Tanaka T; Takeuchi H
    No To Shinkei; 1998 Jan; 50(1):56-60. PubMed ID: 9493200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic vasculitis and p-ANCA positivity developing in a patient with ulcerative colitis and the antiphospholipid syndrome.
    Satchell SC; Anthony P; Nicholls AJ
    Nephron; 1999; 83(4):365-7. PubMed ID: 10575302
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
    Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
    Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.